Companies/US/PTHS

PELTHOS THERAPEUTICS INC.

Ownership & governance

Proxy officers5

NameRoleSinceShares
John M. GayChief Financial Officer, Secretary and Treasurer since 2026—-
Sai RangaraoChief Commercial Officer since 2025 Scott M—-
Tenure Scott PleshaChief Executive Officer and President since 2025—-
Richard BaxterDirector or executive officer2025-07-0125,779
Richard MalamutDirector or executive officer2023-01-0136,800

Filing shareholders10

NameOwnershipShares
Murchinson Ltd7.30%280,000
Ikarian Capital LLC6.70%256,598
Ezra Friedberg5.50%211,452
Francis Knuettel II3.50%138,140
and Named Executive Officers2.90%112,893

Proxy · as of 2026-09-29

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus strong buyMean target 51.71Range 40–64Analysts 7
40Mean 51.7164
  • Strong buy 1
  • Buy 6

Broker actions14

FirmActionToTargetDate
Lake StreetMaintainedBuy402026-10-12
OppenheimerMaintainedOutperform642026-08-14
OppenheimerMaintainedOutperform662026-05-15
Cantor FitzgeraldInitiatedOverweight502026-04-01
OppenheimerMaintainedOutperform622026-03-20
HC Wainwright & Co.ReiteratedBuy602026-03-19
Piper SandlerInitiatedOverweight482026-02-27
Roth CapitalMaintainedBuy552026-02-26
OppenheimerMaintainedOutperform602026-01-26
Lake StreetInitiatedBuy502025-12-03
HC Wainwright & Co.InitiatedBuy602025-12-03
Roth CapitalInitiatedBuy572025-11-25

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers